Level and prognostic value of serum myeloperoxidase in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention

Circulation Journal

Volumn 73, Issue 4, 2009, Pages 726-731

  Chang, Li Teh ^b   Chua, Sarah ^a   Sheu, Jiunn Jye ^a   Wu, Chiung Jen ^a   Yeh, Kuo Ho ^a   Yang, Cheng Hsu ^a   Yip, Hon Kan ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b MEIHO UNIVERSITY   (Taiwan)

Author keywords

Acute myocardial infarction; Major adverse clinical events; Myeloperoxidase

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CREATINE KINASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ISONITRATE; LOW DENSITY LIPOPROTEIN; MYELOPEROXIDASE; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY RISK; CORONARY STENT; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LEUKOCYTE COUNT; LIPID OXIDATION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; ST SEGMENT ELEVATION; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEROXIDASE; PREDICTIVE VALUE OF TESTS; TIME FACTORS;

EID: 65649143449     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0577     Document Type: Article

References (36)

1. Murray GJL, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349: 1436-1442. (Pubitemid 27212192)
2. Murray GJL, Lopez AD. Mortality by cause for eight regions of the word: Global Burden of Disease Study. Lancet 1997; 349: 1269-1276. (Pubitemid 27192468)
3. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999; 340: 115-126.
4. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143. (Pubitemid 34212626)
5. Yip HK, Sun CK, Chang LT, Wu CJ. Strong correlation between serum levels of inflammatory mediators and their distribution in infarct-related coronary artery. Circ J 2006; 70: 838-845. (Pubitemid 43979119)
6. Chisolm GM, Steinberg D. The oxidative modification hypothesis of atherosclerosis: A new review. Free Radic Biol Med 2000; 28: 1815-1826. (Pubitemid 30628668)
7. Heinecke JW. Oxidative stress: New approach to diagnosis and prognosis in atherosclerosis. Am J Cardiol 2003; 91: 12A-16A.
8. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004; 84: 1381-1478. (Pubitemid 39302636)
9. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657-671.
10. Podrez EA, Abu-Sound HM, Hazen SL. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med 2000; 28: 1815-1826. (Pubitemid 30628658)
11. Zhang R, Brennan ML, Shen Z, MacPherson JC, Schmitt D, Molenda CE, et al. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J Biol Chem 2002; 277: 46116-46122. (Pubitemid 35417600)
12. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996; 20: 707-727. (Pubitemid 26105783)
13. Klebanoff SJ. Myeloperoxidase. Proc Assoc Am Physicians 1999; 111: 383-389.
14. Lau D, Baldus S. Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharm Therap 2006; 111: 16-26. (Pubitemid 43765542)
15. Heinecke JW. Oxidative stress: New approaches to diagnosis and prognosis in atherosclerosis. Am J Cardiol 2003; 91: 12A-16A. (Pubitemid 36351458)
16. Rutgers A, Heeringa P, Tervaert JW. The role of myeloperoxidase in the pathogenesis of systemic vasculitis. Clin Exp Rheumatol 2003; 21: 55-63. (Pubitemid 38016480)
17. Naruko T, Ueda M, Haze K, Van der Wal AC, van der Loos CM, Itoh A, et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002; 106: 2894-2900. (Pubitemid 35424738)
18. Vita JA, Brennan ML, Gokce N, Mann SA, Goormastic M, Shishehbor MH, et al. Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation 2004; 110: 1134-1139. (Pubitemid 39319014)
19. Zhang R, Brennan ML, Fu X, Aviles RJ, Pearce GL, Penn MS, et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 2001; 286: 2136-2142. (Pubitemid 34041599)
20. Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Muzel T, et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003; 108: 1440-1445. (Pubitemid 37176448)
21. Mocatta TJ, Pilbrow AP, Cameron VA, Senthilmohan R, Frampton CM, Richards AM, et al. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J Am Coll Cardiol 2007; 49: 1993-2000. (Pubitemid 46734639)
22. Cavusoglu E, Ruwende C, Eng C, Chopra V, Yanamadala S, Clark LT, et al. Useful of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome. Am J Cardiol 2007; 99: 1364-1368. (Pubitemid 46686633)
23. Dominguez-Rodriguez A, Samimi-Fart S, Abreu-Gounalez P, Garcia- Gonzalez MJ, Kaski JK. Prognostic value of admission myeloperoxidase levels in patients with ST-segment elevation myocardial infarction and cardiogenic shock. Am J Cardiol 2008; 101: 1537-1540.
24. Yip HK, Chen MC, Chang HW, Hang CL, Hsieh YK, Fang CY, et al. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: Predictors of slow-flow and no-reflow. Chest 2002; 122: 1322-1332. (Pubitemid 35339548)
25. Yip HK, Wu CJ, Chang HW, Fang CY, Yang CH, Chen SM, et al. Effect of the PercuSurge GuardWire Device on the integrity of microvasculature and clinical outcomes during primary transradial coro nary intervention in acute myocardial infarction. Am J Cardiol 2003; 92: 1331-1335. (Pubitemid 37431146)
26. Yip HK, Wu CJ, Chang HW, Yang CH, Yeh KH, Chua S, et al. Levels and values of serum high-sensitivity C-reactive protein within six hours after the onset of an acute myocardial infarction. Chest 2004; 126: 1417-1422. (Pubitemid 39525011)
27. Yip HK, Wu CJ, Yang CH, Chang HW, Fang CY, Hung WC, et al. Serial changes in circulating levels of soluble CD40 ligand and Creactive protein in patients with unstable angina undergoing coronary stenting: Role of inflammatory mediators in predicting late restenosis. Circ J 2005; 69: 890-895. (Pubitemid 41124254)
28. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury mechanisms of disease. N Engl J Med 2007; 357: 1121-1139.
29. Zhang C, Yang J, Jacobs JD, Jennings LK. Interaction of myeloperoxidase with vascular NAD(P)H oxidase-derived reactive oxygen species in vasculature: Implications for vascular diseases. Am J Physiol Heart Circ Physiol 2003; 285: H2563-H2572. (Pubitemid 37443074)
30. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997; 336: 1276-1282. (Pubitemid 27187780)
31. Mulvihill NT, Foley JB. Inflammation in acute coronary syndromes. Heart 2002; 87: 201-204. (Pubitemid 34177667)
32. Hurst JK, Barrette Jr WC. Leukocytic oxygen and microbicidal oxidative toxins. Crit Rev Biochem Mol Biol 1989; 24: 271-328.
33. Mueller C, Buettner HJ, Hodgson JM, Marsch S, Perruchoud AP, Roskamm H, et al. Inflammation and long-term mortality after non- ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients. Circulation 2002; 105: 1412-1415. (Pubitemid 34263269)
34. Valgimigli M, Ceconi C, Malagutti P, Merli E, Soukhomovskaia O, Francolini G, et al. Tumor necrotic factor-α receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction. Circulation 2005; 111: 863-870.
35. Youssef AA, Change LT, Hang CL, Wu CJ, Cheng CI, Yang CH, et al. Level and value of interleukin-18 in patients with acute myocardial infarction undergoing primary coronary angioplasty. Circ J 2007; 71: 703-708. (Pubitemid 46683361)
36. Barron HV, Cannon CP, Murphy SA, Braunwald E, Gibson M. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: A thrombolysis in myocardial infarction 10 substudy. Circulation 2000; 102: 2329-2334.